A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19
Phase: PHASE1
Conditions: Corona Virus Infection
Sponsor: Sironax USA, Inc.



SIR365-US-101 Clinical Study Report
460

SIR365-US-101 Clinical Study Report
461

SIR365-US-101 Clinical Study Report
462

SIR365-US-101 Clinical Study Report
463

SIR365-US-101 Clinical Study Report
464

SIR365-US-101 Clinical Study Report
465

SIR365-US-101 Clinical Study Report
466

SIR365-US-101 Clinical Study Report
467

SIR365-US-101 Clinical Study Report
481

SIR365-US-101 Clinical Study Report
482

SIR365-US-101 Clinical Study Report
484

SIR365-US-101 Clinical Study Report
485

SIR365-US-101 Clinical Study Report
487

SIR365-US-101 Clinical Study Report
493

SIR365-US-101 Clinical Study Report
494

SIR365-US-101 Clinical Study Report
496

SIR365-US-101 Clinical Study Report
499

SIR365-US-101 Clinical Study Report
500

SIR365-US-101 Clinical Study Report
501

SIR365-US-101 Clinical Study Report
504

SIR365-US-101 Clinical Study Report
505

SIR365-US-101 Clinical Study Report
506

SIR365-US-101 Clinical Study Report
507

SIR365-US-101 Clinical Study Report
508

SIR365-US-101 Clinical Study Report
509

SIR365-US-101 Clinical Study Report
510

SIR365-US-101 Clinical Study Report
511

SIR365-US-101 Clinical Study Report
512

SIR365-US-101 Clinical Study Report
513

SIR365-US-101 Clinical Study Report
514

SIR365-US-101 Clinical Study Report
515

SIR365-US-101 Clinical Study Report
520

SIR365-US-101 Clinical Study Report
521

SIR365-US-101 Clinical Study Report
522

SIR365-US-101 Clinical Study Report
523

SIR365-US-101 Clinical Study Report
524

SIR365-US-101 Clinical Study Report
525

SIR365-US-101 Clinical Study Report
526

SIR365-US-101 Clinical Study Report
529

SIR365-US-101 Clinical Study Report
530

SIR365-US-101 Clinical Study Report
539

SIR365-US-101 Clinical Study Report
540